Tag: CAVT
THUNDER study demonstrates safety and effectiveness of modulated aspiration in stroke...
Penumbra announced the results of THUNDER, which is an investigational device exemption (IDE) study intended to evaluate the safety and effectiveness of Thunderbolt—the company's...
First patient enrolled in Penumbra’s FORWARD study of mechanical thrombectomy for...
Penumbra has announced the initiation of its FORWARD study, an international, real-world prospective, multicentre study. The study will collect safety and efficacy data on...
New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of the STORM-PE randomised controlled trial (RCT) have demonstrated that patients with acute intermediate-high risk pulmonary embolism (PE) who were treated...
Penumbra unveils latest iteration of thrombectomy system for venous thromboembolism
Penumbra has launched the Lightning Flash 3.0 computer-assisted vacuum thrombectomy (CAVT) system, a development that includes "significant upgrades" to the venous thromboembolism (VTE) platform,...
Boston Scientific announces agreement to acquire Penumbra
Boston Scientific and Penumbra today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash...
CAVT with anticoagulation significantly improves functional outcomes in PE patients, RCT...
Mechanical thrombectomy by means of computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra) along with anticoagulation for acute-to-intermediate pulmonary embolism (PE)...
STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra), with anticoagulation achieves superior reduction in right...
Penumbra’s STORM-PE randomised trial completes enrolment
Penumbra has announced the completion of enrolment in the STORM-PE clinical trial.
The pivotal, prospective, multicentre randomised controlled trial enrolled 100 patients to evaluate computer...
Penumbra announces completion of enrolment in THUNDER IDE study
Penumbra has announced the completion of enrolment in its THUNDER investigational device exemption (IDE) clinical study for patients with acute ischaemic stroke.
THUNDER is evaluating...
Computer-assisted vacuum thrombectomy (CAVT) system ‘revolutionises’ pulmonary embolism treatment
This advertorial, sponsored by Penumbra, is intended only for readers outside the USA.
“The advances led by this technology have significantly revolutionised our procedures,” states...
